(Q39939863)

15 September 2017

title

A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis (English)

1 reference

15 September 2017

1 reference

Günter Köhler

1

1 reference

15 September 2017

Thomas A Faustmann

2

1 reference

15 September 2017

Christoph Gerlinger

3

1 reference

15 September 2017

Christian Seitz

4

1 reference

15 September 2017

Alfred O Mueck

5

1 reference

15 September 2017

publication date

1 January 2010

1 reference

International Journal of Gynecology and Obstetrics

15 September 2017

published in

1 reference

15 September 2017

volume

108

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

21-25

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

15 September 2017

1 reference

Progestogens for endometriosis: forward to the past

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

A call for more transparency of registered clinical trials on endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

Hormonal and histological study on irregular genital bleeding in patients with endometriosis during treatment with dienogest, a novel progestational therapeutic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

High-dose pilot study with the novel progestogen dienogestin patients with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

Revised American Society for Reproductive Medicine classification of endometriosis: 1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

Effect of dienogest-containing oral contraceptives on lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

Medical and surgical therapies for pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

ESHRE guideline for the diagnosis and treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2009.08.020

10.1016/J.IJGO.2009.08.020

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference